Emami to acquire remaining 73.5% stake in Axiom Ayurveda for up to ₹200 Cr
Emami Limited will acquire the remaining ~73.5% stake in Axiom Ayurveda for up to ₹200 crore. The deal marks Emami's entry into the beverage sector and is expected to close within three months. Axiom Ayurveda, with brands like "AloFrut", is projected to achieve ₹180 crore topline in FY26. Mr. Harkirat Bedi has been appointed as Axiom's CEO.
This is a significant strategic move for Emami, marking a formal entry into the beverage sector, which is a large and growing market. The acquisition is expected to contribute substantially to the company's topline and future growth trajectory.
The acquisition represents a strategic expansion into a new, high-growth category (beverages) for Emami Limited, which is expected to contribute to future revenue and profitability. The appointment of a new CEO also signals a focus on accelerating growth.
Emami Limited has executed a definitive agreement to acquire the remaining approximately 73.5% stake in Axiom Ayurveda Pvt. Ltd. for an aggregate consideration not exceeding ₹200 crores. This acquisition marks Emami's formal entry into the beverage sector. The transaction, approved by Emami's Board of Directors, is expected to be completed within the next three months, subject to customary closing conditions.
Axiom Ayurveda's portfolio includes beverage products under the "AloFrut" brand, health juices under "Axiom Jeevan Ras", and beauty products under "Mukti Gold". The company is projected to achieve a topline of around ₹180 crore in FY26.
As part of the development, Mr. Harkirat Bedi, formerly Vice President & Business Head at Dabur Nepal, has been appointed as the Chief Executive Officer of Axiom Ayurveda Pvt. Ltd. to accelerate its expansion in the health and wellness beverage segment.
What to do with a filing like this
Emami Limited filed this with the NSE as a statutory disclosure, categorised under acquisition. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Emami Limited. Read the original for the full detail.